Table 2.
Comparison of mean biophysical and permeability parameters of in vitro expressed Cav3 channels (±SE; n values in parentheses)
ParameterTCav3LCav3 (+8b-25c)P-valueRef.Cav3.1P-valueRef.Cav3.2P-valueRef.Cav3.3P-valueRef.
Activation              
Peak of IV (mV) −45 −40  −35  −35  25  
V1/2 −59.32 ± 0.9 (8) −53.48 ± 0.34 (13) *** −49.3 ± 0.7 (26) *** −48.4 ± 1.2 (10) *** 41.5 ± 1.1 (17) *** 
Slope (k, mV) 4.50 ± 0.25 (8) 5.46 ± 0.14 (13) ** 4.6 ± 0.1 (26) NS 5.2 ± 0.4 (10) NS 6.2 ± 0.2 (17) *** 
Inactivation              
V1/2 −74.15 ± 0.90 (10) −70.89 ± 0.49 (16) ** −74.2 ± 1.1 (8) NS −75.6 ± 0.7 (19) NS 69.8 ± 0.9 (17) ** 
Slope (k, mV) 2.69 ± 0.11 (8) 2.93 ± 0.08 (16) NS 5.5 ± 0.3 (8) *** 6.2 ± 0.2 (19) *** 6.1 ± 0.1 (17) *** 
Activation kinetics             
τ (−50 mV) 14.36 ± 0.31 (8) 3.26 ± 0.13 (16) *** 8.2 ± 0.9 (8) *** 9.9 ± 0.4 (10) *** 43 ± 3 (9) *** 
τ (−10 mV) 3.48 ± 0.13 (8) 0.74 ± 0.03 (16) *** 1.1 ± 0.1 (8) *** 1.8 ± 0.1 (10) *** 5.9 ± 0.5 (9) *** 
Fold change 4.1 4.4   7.5   5.5   7.3   
Inactivation kinetics             
τ (−50 mV) 66.33 ± 3.39 (6) 27.51 ± 1.34 (16) *** 62 ± 23 (8) NS 28 ± 3 (10) *** 126 ± 22 (9) 
τ (−10 mV) 51.36 ± 1.53 (6) 15.67 ± 0.56 (16) *** 16 ± 1 (8) *** 15 ± 1 (10) *** 80 ± 5 (9) *** 
Fold change 1.3 1.8   3.9   1.9   1.6   
Deactivation              
−100 mV 1.46 ± 0.06 (12) 1.37 ± 0.05 (19) NS 2.6 ± 0.2 (9) *** 3.6 ± 0.4 (14) *** 1.12 ± 0.1 (31) 
−70 mV 9.15 ± 0.66 (12) 2.28 ± 0.18 (19) *** 6.2 ± 0.4 (9) ** 8.5 ± 1.1 (14) NS 2.1 ± 0.1 (30) *** 
Recovery              
τ recovery (ms) 1275.05 ± 54.43 (6) 908.04 ± 27.05 (14) *** 137 ± 5 (12) *** 448 ± 36 (7) *** 260 ± 30 (18) *** 
Nickel              
(IC50 µM) 335.0 ± 6.5 (9) 300.0 ± 29.2 (4) NS 304.8 ± 6.2 (5–6) 4.9 ± 2.0 (5–6) *** 216 ± 9 (5-6) *** 
Mixed Ca2+/Na+ currents             
% increase in Imax (Ca2+42.09 ± 3.19 (8) 12a: 1439.75 ± 82.50 (6) *** 26.64 ± 9.24 (4)  31.96 ± 4.58 (11) NS  45.45 ± 7.59 (6) NS  
  12b: 153.02 ± 9.61 (7) ***          
% increase in Imax (Ba2+51.19 ± 2.64 (4) 12a: 901.29 ± 120.33 (5) *** 27.01 ± 3.17 (9) *** 36.88 ± 3.50 (7) 49.91 ± 6.23 (4) NS 
  12b: 121.07 ± 4.26 (3) ***          
Ca2+ vs. X+ permeability             
pCa/pLi 19.87 ± 1.30 (8) 12a: 22.74 ± 0.41 (8) 46.67 ± 2.32 (7) ***       
  12b: 27.40 ± 1.13 (7) ***          
pCa/pNa 35.61 ± 1.52 (8) 12a: 33.06 ± 1.50 (6) NS 89.56 ± 8.21 (6) *** 80.58 ± 3.69 (4) ***  56.19 ± 2.99 (7) ***  
  12b: 41.49 ± 1.98 (8)          
pCa/pK 63.99 ± 4.19 (9) 12a: 50.25 ± 1.56 (12) ** 140.16 ± 12.02 (5) ***       
  12b: 78.93 ± 4.17 (11)          
pCa/pCs 114.83 ± 10.64 (7) 12a: 111.30 ± 8.57 (10) NS 154.65 ± 7.99 (5)       
  12b: 113.76 ± 7.19 (11) NS          
ParameterTCav3LCav3 (+8b-25c)P-valueRef.Cav3.1P-valueRef.Cav3.2P-valueRef.Cav3.3P-valueRef.
Activation              
Peak of IV (mV) −45 −40  −35  −35  25  
V1/2 −59.32 ± 0.9 (8) −53.48 ± 0.34 (13) *** −49.3 ± 0.7 (26) *** −48.4 ± 1.2 (10) *** 41.5 ± 1.1 (17) *** 
Slope (k, mV) 4.50 ± 0.25 (8) 5.46 ± 0.14 (13) ** 4.6 ± 0.1 (26) NS 5.2 ± 0.4 (10) NS 6.2 ± 0.2 (17) *** 
Inactivation              
V1/2 −74.15 ± 0.90 (10) −70.89 ± 0.49 (16) ** −74.2 ± 1.1 (8) NS −75.6 ± 0.7 (19) NS 69.8 ± 0.9 (17) ** 
Slope (k, mV) 2.69 ± 0.11 (8) 2.93 ± 0.08 (16) NS 5.5 ± 0.3 (8) *** 6.2 ± 0.2 (19) *** 6.1 ± 0.1 (17) *** 
Activation kinetics             
τ (−50 mV) 14.36 ± 0.31 (8) 3.26 ± 0.13 (16) *** 8.2 ± 0.9 (8) *** 9.9 ± 0.4 (10) *** 43 ± 3 (9) *** 
τ (−10 mV) 3.48 ± 0.13 (8) 0.74 ± 0.03 (16) *** 1.1 ± 0.1 (8) *** 1.8 ± 0.1 (10) *** 5.9 ± 0.5 (9) *** 
Fold change 4.1 4.4   7.5   5.5   7.3   
Inactivation kinetics             
τ (−50 mV) 66.33 ± 3.39 (6) 27.51 ± 1.34 (16) *** 62 ± 23 (8) NS 28 ± 3 (10) *** 126 ± 22 (9) 
τ (−10 mV) 51.36 ± 1.53 (6) 15.67 ± 0.56 (16) *** 16 ± 1 (8) *** 15 ± 1 (10) *** 80 ± 5 (9) *** 
Fold change 1.3 1.8   3.9   1.9   1.6   
Deactivation              
−100 mV 1.46 ± 0.06 (12) 1.37 ± 0.05 (19) NS 2.6 ± 0.2 (9) *** 3.6 ± 0.4 (14) *** 1.12 ± 0.1 (31) 
−70 mV 9.15 ± 0.66 (12) 2.28 ± 0.18 (19) *** 6.2 ± 0.4 (9) ** 8.5 ± 1.1 (14) NS 2.1 ± 0.1 (30) *** 
Recovery              
τ recovery (ms) 1275.05 ± 54.43 (6) 908.04 ± 27.05 (14) *** 137 ± 5 (12) *** 448 ± 36 (7) *** 260 ± 30 (18) *** 
Nickel              
(IC50 µM) 335.0 ± 6.5 (9) 300.0 ± 29.2 (4) NS 304.8 ± 6.2 (5–6) 4.9 ± 2.0 (5–6) *** 216 ± 9 (5-6) *** 
Mixed Ca2+/Na+ currents             
% increase in Imax (Ca2+42.09 ± 3.19 (8) 12a: 1439.75 ± 82.50 (6) *** 26.64 ± 9.24 (4)  31.96 ± 4.58 (11) NS  45.45 ± 7.59 (6) NS  
  12b: 153.02 ± 9.61 (7) ***          
% increase in Imax (Ba2+51.19 ± 2.64 (4) 12a: 901.29 ± 120.33 (5) *** 27.01 ± 3.17 (9) *** 36.88 ± 3.50 (7) 49.91 ± 6.23 (4) NS 
  12b: 121.07 ± 4.26 (3) ***          
Ca2+ vs. X+ permeability             
pCa/pLi 19.87 ± 1.30 (8) 12a: 22.74 ± 0.41 (8) 46.67 ± 2.32 (7) ***       
  12b: 27.40 ± 1.13 (7) ***          
pCa/pNa 35.61 ± 1.52 (8) 12a: 33.06 ± 1.50 (6) NS 89.56 ± 8.21 (6) *** 80.58 ± 3.69 (4) ***  56.19 ± 2.99 (7) ***  
  12b: 41.49 ± 1.98 (8)          
pCa/pK 63.99 ± 4.19 (9) 12a: 50.25 ± 1.56 (12) ** 140.16 ± 12.02 (5) ***       
  12b: 78.93 ± 4.17 (11)          
pCa/pCs 114.83 ± 10.64 (7) 12a: 111.30 ± 8.57 (10) NS 154.65 ± 7.99 (5)       
  12b: 113.76 ± 7.19 (11) NS          

P-values for statistical comparisons for all channels with respect to TCav3 were generated using one-way ANOVA. *, P < 0.05; **, P < 0.005; ***, P < 0.0005; NS, not significantly different. Bold indicates the value most similar to TCav3, and bold italics indicates the value most different from TCav3. References: 1, Senatore and Spafford (2012); 2, Chemin et al. (2002); 3, Gomora et al. (2002); 4, Senatore and Spafford (2010); 5, Kang et al. (2006); 6, Senatore et al. (2014).

or Create an Account

Close Modal
Close Modal